Long-term bulevirtide treatment safe, effective for chronic hepatitis D
17 Sep 2026
byStephen Padilla
Treatment with bulevirtide monotherapy for up to 144 weeks is safe, well tolerated, and effective in patients with chronic hepatitis D (CHD), a study has shown.
Long-term bulevirtide treatment safe, effective for chronic hepatitis D
17 Sep 2026